We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Family Study in Schizophrenia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2008 by Sheba Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00418912
First Posted: January 5, 2007
Last Update Posted: February 15, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose

Schizophrenia is a severe mental illness which is considered to have, among other, a genetic etiology. One of the most efficient tools in genetic-psychiatry is the investigation of multiplex families.

The current study will identify patients of multiplex families and to map their family connections and the presence of mental illnesses among family members.


Condition
Schizophrenia Family Genetics

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 100
Study Start Date: March 2007
Estimated Study Completion Date: January 2009
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
schizophrenia
Criteria

Inclusion Criteria:

  1. Schizophrenia
  2. Multiplex family
  3. Able to understand and sign the informed concent form.
  4. Hebrew speaker
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00418912


Contacts
Contact: Raz Gross, MD 972-3-5303962 razg@gertner.health.gov.il
Contact: Michael Bunzel, MD 972-3-530

Locations
Israel
Psychiatric unit, Sheba Medical Center Recruiting
Tel Hashomer, Israel, 52621
Contact: Michael Bunzel, MD       chiba2@actcom.net.il   
Principal Investigator: Michael Bunzel, MD         
Seba Medical Center Recruiting
Tel Hashomer, Israel
Contact: Michael Bunzel, MD         
Principal Investigator: Michaael Bunzel, MD         
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Raz Gross, MD Mental Health Epidemiology & Psychosocial Aspects of Illness, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer , Israel
Study Director: Michael Bunzel, MD Psychiatric Unit, Sheba Medical Center, Tel Hashomer, Israel
  More Information

Responsible Party: Raz Gross, Head, Mental Health Epidemiology, The Gertner Institute for Epidemiology
ClinicalTrials.gov Identifier: NCT00418912     History of Changes
Other Study ID Numbers: SHEBA-06-4329-RG-CTIL
First Submitted: January 4, 2007
First Posted: January 5, 2007
Last Update Posted: February 15, 2008
Last Verified: February 2008

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders